Global Neurovascular Devices Market 2023

November 2023 | 87 pages | ID: GE710CEE34D0EN
Gen Consulting Company

Abstracts

Neurovascular devices are specialized medical devices designed for the treatment, and management of conditions affecting the blood vessels and blood flow within the brain and spinal cord. These devices play a crucial role in the field of neurointerventional surgery and are used to address a wide range of neurovascular disorders, including aneurysms, arteriovenous malformations (AVMs), stroke, and other vascular abnormalities.

According to the latest data, the market size of the global neurovascular devices sector is expected to rise by USD 1.3 billion with a CAGR of 6.2% by the end of 2029.

This comprehensive industry report provides market estimates and forecasts, accompanied by a detailed examination of the product, application, end user, and region aspects. It delivers a quantitative analysis of the market, empowering stakeholders to leverage existing market opportunities. Furthermore, the report identifies key segments for potential opportunities and strategies, drawing insights from market trends and the approaches of leading competitors.

The global baby bottle market has been extensively analyzed by categorizing it according to various sub-segments in order to provide accurate forecasts of industry size and assess trends within specific areas.

The global market for neurovascular devices can be segmented by product: access devices (microcatheters, guidewires), angioplasty and stenting (carotid stenting, embolic protection systems), embolization devices (embolic coils, flow diverters, liquid embolic agents), thrombectomy devices (clot retrieval devices, suction & aspiration devices, snares). The embolization devices segment captured the largest share of the market in 2022.

Neurovascular devices market is further segmented by application: arteriovenous malformation and fistulas (AVM), cerebral aneurysm, cerebral artery stenosis, ischemic strokes.

Based on end user, the neurovascular devices market is segmented into: hospitals, specialized clinics, others. In 2022, the hospitals segment made up the largest share of revenue generated by the neurovascular devices market.

On the basis of region, the neurovascular devices market also can be divided into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America. North America was the highest contributor to the global neurovascular devices market. Going forward, Asia-Pacific is projected to witness the highest CAGR during the forecast period.

The global neurovascular devices market report offers detailed information on several market vendors, including Acandis GmbH, Contego Medical, Inc., Endologix LLC, Integer Holdings Corporation, Johnson & Johnson, Medtronic plc, MicroPort Scientific Corporation, Penumbra, Inc., Rapid Medical Ltd., Stryker Corporation, Terumo Corporation, among others. In this report, key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.

Why Choose This Report

Gain a reliable outlook of the global neurovascular devices market forecasts from 2023 to 2029 across scenarios.

Identify growth segments for investment.

Stay ahead of competitors through company profiles and market data.

The market estimate for ease of analysis across scenarios in Excel format.

Strategy consulting and research support for three months.

Print authentication provided for the single-user license.

Market Segments Covered in Global Neurovascular Devices Industry Analysis:

i.) Product

• Access devices (microcatheters, guidewires)
• Angioplasty and stenting (carotid stenting, embolic protection systems)
• Embolization devices (embolic coils, flow diverters, liquid embolic agents)
• Thrombectomy devices (clot retrieval devices, suction & aspiration devices, snares)

ii.) Application

• Arteriovenous malformation and fistulas (AVM)
• Cerebral aneurysm
• Cerebral artery stenosis
• Ischemic strokes

iii.) End user

• Hospitals
• Specialized clinics
• Others

iv.) Region

• North America
• Europe
• Asia-Pacific
• MEA (Middle East and Africa)
• Latin America

Contents

PART 1. INTRODUCTION

1.1 Description
1.2 Objectives of The Study
1.3 Market Segment
1.4 Years Considered for The Report
1.5 Currency
1.6 Key Target Audience

PART 2. RESEARCH METHODOLOGY

2.1 Primary Research
2.2 Secondary Research

PART 3. EXECUTIVE SUMMARY


PART 4. MARKET OVERVIEW

4.1 Introduction
4.2 Drivers
4.3 Restraints

PART 5. GLOBAL NEUROVASCULAR DEVICES MARKET BY PRODUCT

5.1 Access devices (microcatheters, guidewires)
5.2 Angioplasty and stenting (carotid stenting, embolic protection systems)
5.3 Embolization devices (embolic coils, flow diverters, liquid embolic agents)
5.4 Thrombectomy devices (clot retrieval devices, suction & aspiration devices, snares)

PART 6. GLOBAL NEUROVASCULAR DEVICES MARKET BY APPLICATION

6.1 Arteriovenous malformation and fistulas (AVM)
6.2 Cerebral aneurysm
6.3 Cerebral artery stenosis
6.4 Ischemic strokes

PART 7. GLOBAL NEUROVASCULAR DEVICES MARKET BY END USER

7.1 Hospitals
7.2 Specialized clinics
7.3 Others

PART 8. GLOBAL NEUROVASCULAR DEVICES MARKET BY REGION

8.1 North America
8.2 Europe
8.3 Asia-Pacific
8.4 MEA (Middle East and Africa)
8.5 Latin America

PART 9. COMPANY PROFILES

9.1 Acandis GmbH
9.2 Contego Medical, Inc.
9.3 Endologix LLC
9.4 Integer Holdings Corporation
9.5 Johnson & Johnson
9.6 Medtronic plc
9.7 MicroPort Scientific Corporation
9.8 Penumbra, Inc.
9.9 Rapid Medical Ltd.
9.10 Stryker Corporation
9.11 Terumo Corporation
DISCLAIMER